Form4insider filings, from the source

SEC Form 4 · accession 0001140361-17-008017

IDEXX LABORATORIES INC /DE · IDXX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Jonathan W Ayers
Officer — Chairman, President & CEO · Director
Period of report
Feb 14, 2017
Accepted (ET)
Feb 16, 2017 · 7:20 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000874716

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockFeb 14, 2017M2,400$0.00A992,886D
Common StockFeb 14, 2017M2,160$0.00A995,046D
Common StockFeb 14, 2017M1,774$0.00A996,820D
Common StockF1Feb 14, 2017F3,159$141.60D993,661D
Common Stockholding———98,000Iby Ayers Family Trust

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Non-Qualified Stock Option (right-to-buy)F6,F2$141.60Feb 14, 2017A110,211A—Feb 13, 2027Common Stock110,211110,211D
Incentive Stock Option (right-to-buy)F6,F2$141.60Feb 14, 2017A706A—Feb 13, 2027Common Stock706706D
Restricted Stock UnitF6,F3—Feb 14, 2017M2,400D——Common Stock2,4009,642D
Restricted Stock UnitF6,F4—Feb 14, 2017M2,160D——Common Stock2,1607,482D
Restricted Stock UnitF6,F5—Feb 14, 2017M1,774D——Common Stock1,7745,708D

Explanation of responses